Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates

Annals of Neurology

Volumn 66, Issue 3, 2009, Pages 343-354

  Pluchino, Stefano ^a,i   Gritti, Angela ^b   Blezer, Erwin ^c   Amadio, Stefano ^a   Brambilla, Elena ^a   Borsellino, Giovanna ^d   Cossetti, Chiara ^a,e   Del Carro, Ubaldo ^a   Comi, Giancarlo ^a   'T Hart, Bert ^f,g   Vescovi, Angelo ^h,i   Martino, Gianvito ^a,i  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^e UNIVERSITY OF PORTO   (Portugal)

^f BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h UNIVERSITY OF MILANO BICOCCA   (Italy)

ⁱ NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISABILITY; FEASIBILITY STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; MARMOSET; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEURAL STEM CELL TRANSPLANTATION; NEUROPATHOLOGY; NONHUMAN; PRIMATE; PRIORITY JOURNAL; SAFETY; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

ANIMALS; CALLITHRIX; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; LYMPH NODES; MULTIPLE SCLEROSIS; MULTIPOTENT STEM CELLS; NERVE REGENERATION; NEURONS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HETEROLOGOUS;

EID: 70350070212     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.21745     Document Type: Article

References (41)

1. Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008;9:839-855.
2. Pluchino S, Furlan R, Martino G. Cell-based remyelinating therapies in multiple sclerosis: evidence from experimental studies. Curr Opin Neurol 2004;17:247-255. (Pubitemid 38720975)
3. Pluchino S, Quattrini A, Brambilla E, et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 2003;422:688-694. (Pubitemid 36514101)
4. Einstein O, Karussis D, Grigoriadis N, et al. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci 2003;24:1074-1082. (Pubitemid 38091518)
5. Aharonowiz M, Einstein O, Fainstein N, et al. Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS One 2008;3:e3145.
6. Martino G, Pluchino S. The therapeutic potential of neural stem cells. Nat Rev Neurosci 2006;7:395-406.
7. Pluchino S, Zanotti L, Rossi B, et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005;436:266-271. (Pubitemid 41021278)
8. Einstein O, Fainstein N, Vaknin I, et al. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann Neurol 2007;61:209-218. (Pubitemid 46557345)
9. Blezer EL, Bauer J, Brok HP, et al. Quantitative MRIpathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis. NMR Biomed 2007;20:90-103. (Pubitemid 46470931)
10. Lucchinetti C, Bruck W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707-717. (Pubitemid 30390191)
11. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004;172: 2731-2738. (Pubitemid 38263654)
12. Sachs DH. Tolerance: of mice and men. J Clin Invest 2003; 111:1819-1821.
13. Merkler D, Schmelting B, Czeh B, et al. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions. Mult Scler 2006; 12:369-374. (Pubitemid 44132577)
14. Ziv Y, Avidan H, Pluchino S, et al. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. Proc Natl Acad Sci U S A 2006;103:13174-13179. (Pubitemid 44338935)
15. Ben-Hur T, Ben-Menachem O, Furer V, et al. Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol Cell Neurosci 2003;24: 623-631. (Pubitemid 37506007)
16. Ben-Hur T, Einstein O, Mizrachi-Kol R, et al. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia 2003;41:73-80. (Pubitemid 36164286)
17. Kap YS, Smith P, Jagessar SA, et al. Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)- induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells. J Immunol 2008;180:1326-1337.
18. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci U S A 2004;101: 7727-7732. (Pubitemid 38658097)
19. Bain B, Vas MR, Lowenstein L. The development of large immature mononuclear cells in mixed leukocyte cultures. Blood 1964;23:108-116.
20. Brok HP, Uccelli A, Kerlero De Rosbo N, et al. Myelin/ oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule. J Immunol 2000;165:1093-1101. (Pubitemid 30484781)
21. Armstrong RJ, Hurelbrink CB, Tyers P, et al. The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease. Exp Neurol 2002;175:98-111. (Pubitemid 34507913)
22. Vescovi AL, Parati EA, Gritti A, et al. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp Neurol 1999;156:71-83. (Pubitemid 29152984)
23. Follenzi A, Ailles LE, Bakovic S, et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000;25:217-222. (Pubitemid 30394997)
24. Rampon C, Weiss N, Deboux C, et al. Molecular mechanism of systemic delivery of neural precursor cells to the brain: assembly of brain endothelial apical cups and control of transmigration by CD44. Stem Cells 2008;26:1673-1682.
25. Hall PE, Lathia JD, Miller NG, et al. Integrins are markers of human neural stem cells. Stem Cells 2006;24:2078-2084. (Pubitemid 44477133)
26. Mueller FJ, Serobyan N, Schraufstatter IU, et al. Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins. Stem Cells 2006;24:2367-2372. (Pubitemid 44674295)
27. McLaren FH, Svendsen CN, Van der Meide P, Joly E. Analysis of neural stem cells by flow cytometry: cellular differentiation modifies patterns of MHC expression. J Neuroimmunol 2001; 112:35-46.
28. Butcher EC, Williams M, Youngman K, et al. Lymphocyte trafficking and regional immunity. Adv Immunol. 1999;72: 209-253.
29. Pluchino S, Zanotti L, Brambilia E, Rovere-Querini P, Capobianco A, Alfaro-Cervello C, Salani G, Cossetti C, Borsellino G, Battistini L, Ponzoni M, Doglino C, Garcia-Verdugo JM, Comi G, Manfredi AA, Martino G. Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function. PLoS One. 2009 June 19;4(6):e5959.
30. t Hart BA, Laman JD, Bauer J, et al. Modelling of multiple sclerosis: lessons learned in a non-human primate. Lancet Neurol 2004;3:588-597.
31. t Hart BA, Smith P, Amor S, et al. MRI-guided immunotherapy development for multiple sclerosis in a primate. Drug Discov Today 2006;11:58-66.
32. Herrmann MM, Gaertner S, Stadelmann C, et al. Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 2005;106:1875-1883. (Pubitemid 41208608)
33. Van Wijmeersch B, Sprangers B, Rutgeerts O, et al. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect. Biol Blood Marrow Transplant 2007;13:627-637. (Pubitemid 46768004)
34. Kassis I, Grigoriadis N, Gowda-Kurkalli B, et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 2008;65:753-761. (Pubitemid 351831453)
35. Park HJ, Lee PH, Bang OY, et al. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem 2008;107:141-151.
36. Gerdoni E, Gallo B, Casazza S, et al. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol 2007;61: 219-227. (Pubitemid 46557346)
37. Inglese M, Grossman RI, Filippi M. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution. J Neuroimaging 2005;15(4 suppl):22S-29S. (Pubitemid 43010529)
38. Pittock SJ, McClelland RL, Achenbach SJ, et al. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease. J Neurol Neurosurg Psychiatry 2005;76:1693-1697.
39. Kinashi T. Intracellular signalling controlling integrin activation in lymphocytes. Nat Rev Immunol 2005;5:546-559. (Pubitemid 40961332)
40. Einstein O, Grigoriadis N, Mizrachi-Kol R, et al. Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis. Exp Neurol 2006;198:275-284.
41. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009;6: e1000029.